patent.fyi
Applications  /  US 2026/0355535
United States Patent Application Publication

US 2026/0355535 A1

Published
Nov 12, 2026
Filed
Feb 18, 2026
Earliest date on the face
Sep 7, 2023
Classification
A61N 5/0622
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Filtered tungsten light source

What ifWhat if a filtered tungsten filament supplies the red illumination?
Claim language“one or more light emitting diodes”

A reflector collects light from a tungsten-halogen lamp, and a bandpass filter selects a red band centered at 650 nm. A relay lens projects an annular mask onto the peripheral retina.

1.2Near infrared retinal illumination

What ifWhat if the retinal illumination uses a near infrared band centered at 810 nm?
Claim language“within the light wavelength range of 600 nm-700 nm”

An 810 nm diode and a bandpass filter supply near infrared light to the projection optics. A separate visible fixation target provides an alignment reference while the projector directs the near infrared light to the peripheral retina.

1.4Rectangular peripheral illumination patch

What ifWhat if the higher irradiance footprint is a filled rectangle confined to one side of the peripheral retina?
Claim language“a defined partial or full annular ring”

A rectangular field stop defines the illuminated footprint, and a projection lens places it at an angular offset from a central fixation target. The edge nearest fixation sets the separation between the illuminated patch and the macula.

1.5Ring with an eccentric center

What ifWhat if a small annulus lies entirely within one peripheral retinal quadrant, with the fovea and macula outside its outer perimeter?
Claim language“positioned inside a perimeter”

An annular emitter feeds an off-axis relay that images the ring into one peripheral quadrant. A fixation target aligns the eye, and the relay sets the ring's outer edge beyond the macular region.

1.5Source patterned central dark zone

What ifWhat if an addressable emitter array creates the central dark region by generating light only at the selected peripheral source positions?
Claim language“absorb, or block, the irradiance level”

The controller energizes the pixels that map to the peripheral annulus and supplies zero drive current to the pixels that map to the fovea and macula. A clear relay images the resulting source pattern onto the retina.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Model eye for optical metrology

An optics metrology bench mounts a red LED projector in front of a model eye with a replaceable pupil aperture and a curved translucent retinal screen. A field optic projects a bright annulus around a dim central region on the screen. A calibrated camera images the screen from behind and measures annular uniformity, edge position, and central irradiance as the model eye shifts laterally.

Component substitution

Annular illumination from a filtered lamp

A quartz tungsten halogen lamp replaces the LEDs, and a bandpass filter in a collimated section transmits light from 625 to 665 nm. A condenser couples the filtered light into a homogenizing light pipe whose exit illuminates an axicon pair. The axicons redistribute the beam into an annulus at a field plane, and an eyepiece maps that annulus to peripheral retinal angles with a lower irradiance at the center.

Parameter or scale variation

Adjustable ring width and diameter

A 650 nm LED illuminates an exchangeable annular aperture at the front focal plane of a 25 mm eyepiece. A set of apertures provides inner and outer radii of 4 and 8 mm, 6 and 10 mm, or 8 and 12 mm. The eyepiece maps aperture radius to field angle by the arctangent of radius divided by focal length, giving nominal annular bands of 9° to 18°, 13° to 22°, and 18° to 26°.

Quadrant sequenced annular LED projection

Four independently driven 640 nm LEDs each feed a light pipe and a condenser that illuminate a separate 90° sector of a common annular field aperture. A shared eyepiece maps the four sectors to contiguous peripheral retinal quadrants surrounding a low-irradiance central region. A controller activates each sector for 10 ms in sequence, completing one cycle every 40 ms and giving each quadrant a 25% duty cycle.

Combination with existing systems

Fundus camera with annular projection

A fundus camera shares its objective with a 660 nm LED projector through a dichroic beamsplitter that transmits near-infrared imaging light and reflects the red projection band. The projector relay places an annular aperture in a plane conjugate to the retina, and the camera uses a near-infrared pass filter to reject reflected projection light. A registration display overlays the projected ring boundaries on the live fundus image so the operator can center the low-irradiance region on the fovea.

Automated or data-driven variant

Gaze stabilized digital annular projection

A 635 nm LED illuminates a digital micromirror array in a retinal projection relay, while a near-infrared camera measures pupil position and corneal reflections. A fixation calibration maps the camera measurements to the micromirror coordinates that correspond to the foveal direction. The controller translates the annular pattern as gaze changes and disables the LED whenever the tracker loses the pupil or the required translation exceeds the calibrated projection field.

Specific version of a part

Myopic defocus through spectacle lenses

A central prescription zone focuses distant objects on the retina. Groups of positive-power lenslets around that zone bring portions of the peripheral image into focus in front of the retina, providing the optical signal used for myopia control.

Individually driven red diode array

Red semiconductor diode packages sit at evenly spaced positions on a circular metal-core circuit board. A constant-current driver controls each diode independently to trim differences in output around the circle.

Filtered 660 nm emission

A red diode with a nominal peak of 660 nm feeds a collimator and a bandpass filter with a 650–670 nm passband. A relay directs the filtered light through the pupil to the retinal field.

Full ring with defined edges

A backlit annular aperture at a field plane defines the inner and outer edges of a 360-degree illuminated band. A relay maps the aperture radii to retinal field angles and places the higher irradiance band around a central low-irradiance region.

Absorbing central field stop

An absorptive disk on a transparent carrier sits at a field plane conjugate to the retina. The relay maps the disk onto the fovea and the selected macular area while the surrounding clear aperture passes light to the peripheral ring.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2021/0038425 A1
Published
Feb 11, 2021
Filed
Oct 15, 2020
Class
A61F 9/007
Document BUS 2021/0339044 A1
Published
Nov 4, 2021
Filed
Jul 19, 2021
Class
A61N 5/0622
Claim 1
Document A
Document B
1.1one or more light emitting diodes (LEDs)
The system, generally referred to by the reference number 20, includes a laser console 22, such as for example the 810 nm near infrared micropulsed diode laser in the preferred embodiment.
B · US 2021/0339044 A1 · ¶ 74
1.2wherein the one or more LEDs transmit ocular bio-stimulation light within the light wavelength range of 600 nm-700 nm to a retina of an eye or eyes of an individual receiving the ocular light therapy
Photobiomodulation (PBM) employs application of high but physiologic intensity visible light to the retina.
B · US 2021/0339044 A1 · ¶ 217
1.3wherein the ocular bio-stimulation light in the wavelength range of 600 nm-700 nm is operative to treat myopia or myopia progression in the eye or eyes of the individual by physiologically stimulating retinal cells in the eye or eyes of the individual
1.4wherein the ocular bio-stimulation light is configured to form a defined partial or full annular ring of a higher irradiance level of the ocular bio-stimulation light that strikes a peripheral retinal region of the eye or eyes of the individual compared to a lower irradiance level or no irradiance of the ocular bio-stimulation light that strikes a fovea and a portion or all of a macula of the eye or eyes of the individual located
a. decrease by at least 0.1% the retinal irradiance from the field of view on spatially separated retinal areas, including partially or completely dysfunctional retinal areas, wherein the decrease continues over the defined long time scale, and increase by at least 0.1% the retinal irradiance from the field of view on spatially separated (other than those in a.) retinal areas, including more functional retinal areas, wherein the increase continues over the defined long timesc
A · US 2021/0038425 A1 · ¶
1.5wherein the fovea and the portion or all of the macula are positioned inside a perimeter of the defined partial or full annular ring, and wherein the ocular light therapy system further comprises one or more optics configured to one or more of, inhibit, attenuate, absorb, or block, the irradiance level of the ocular bio-stimulation light transmitted towards the fovea and the portion or all of the macula.

An empty cell means only that no passage was reproduced there.

Statements in these documents
There are great unmet needs for solutions that provide meaningful vision and vision-related quality of life improvements to patients who suffer from vision loss caused by retinal problems.
A · US 2021/0038425 A1 · ¶ 3
The invention described herein also provides vision improvements, vision stabilization and/or vision restoration benefits to patients who have visual symptoms from, or have suffered visual loss from, diseases, injuries and disorders including, but not limited to, eyes with damaged and/or dysfunctional and/or sensorily deprived retinal cells.
A · US 2021/0038425 A1 · ¶ 7
Cite aspatent.fyi, US 2026/0355535 A1, claim 1, first published 2026-11-19T12:45:34-05:00, https://patent.fyi/US20260355535/, SHA-256 d0ff3cc6d7e4693985bed9c5cd8583454c6191259c498455cad444fb96b070dd
First published
Permanent addresshttps://patent.fyi/US20260355535/
Content fingerprint (SHA-256)d0ff3cc6d7e4693985bed9c5cd8583454c6191259c498455cad444fb96b070dd
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi